• Alteogen, Dr. Soon Jae Park, CEO
• Binex Co. Ltd, Dr. Doo Hyun Kim, CTO & SVP of bioprocessing
• Celltrion, Dr. Stanley Hong, President of R&D
• CJ CheilJedang, Dr. Cho Sung Yoo, Project Leader
• Creagene, Dr Yong Soo Bae, CEO
• Genexine, Dr. Sehwan Yang, MD & Head of Research Institute
• Hanwha Biologics, Dr. Paul Coleman,CEO
• KBSI, Dr. Yoo Jong Shi, Director
• Korea UCB, Mr. Thomas Roberts, Managing Director
• KRIBB, Dr. Young Woo Park, Therapeutic Antibody Research Center
• Green Cross, Dr. Se Ho Kim, Director of Antibody Engineering Unit
• Merck Serono, Mr. Yariv Hefez, VP, Head of BD & Alliance Management Biosimilars
• Mycenax, Taiwan, Dr. Karen Wen, CEO
• NovImmune, Dr. Greg Elson, Head of Manufacturing
• PharmAbcine, Dr. Jin San Yoo, President & CEO
• Protein Sciences Corporation, Dr. Daniel Adams, Executive Chairman
• SK Chemicals, Dr. Hun Taek Kim VP/Director, Life Science R&D Center